LFG
TAK icon

LifePlan Financial Group’s Takeda Pharmaceutical TAK Stock Holding History

LifePlan Financial Group’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$1K Hold
50
– – ﹤0.01% 557
2020
Q2 		$1K Hold
50
– – ﹤0.01% 561
2020
Q1 		$1K Hold
50
– – ﹤0.01% 539
2019
Q4 		$1K Hold
50
– – ﹤0.01% 543
2019
Q3 		$1K Hold
50
– – ﹤0.01% 534
2019
Q2 		$1K Hold
50
– – ﹤0.01% 531
2019
Q1 		$1K Buy
+50
New +$1.01K ﹤0.01% 537

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LifePlan Financial Group's TAK Position: Q3 2020 in Review

LifePlan Financial Group held its Takeda Pharmaceutical (TAK) position steady in Q3 2020 at 50 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #557.

LifePlan Financial Group first reported a position in TAK in Q1 2019 and has held it in 7 quarters since. 310 funds tracked by Wall St. Rank hold TAK as of Q3 2020.

  • LifePlan Financial Group held 50 shares of Takeda Pharmaceutical worth $1K as of Q3 2020.
  • LifePlan Financial Group left its Takeda Pharmaceutical share count unchanged in Q3 2020.
  • Takeda Pharmaceutical made up ﹤0.01% of LifePlan Financial Group's portfolio in Q3 2020, its #557 holding.
  • LifePlan Financial Group first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 7 quarters since.
  • 310 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2020.

Based on LifePlan Financial Group's 13F filing for Q3 2020, filed 30 Oct 2020.